Results 221 to 230 of about 440,184 (328)

Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas. [PDF]

EJHaem
Yanashima K, Furukawa Y, Ishii M, Kinoshita S, Hamano Y, Watanabe N, Tsukune Y, Yasuda H, Ando J, Ando M.   +9 more
europepmc   +1 more source

Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology

Nano Select, EarlyView.
This review highlights pioneering nanosensors designed for real‐time leukemia biomarker detection, integrating advanced nanomaterials such as liposomes, polymeric nanoparticles and quantum dots. It examines electrochemical, optical and magnetic detection mechanisms, the applications across AML, ALL, CML, and CLL subtypes, and clinical translation ...
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Amirhossein Mirzazadeh, Mohammad Siavashi, Niloofar Pilehvari, Mohammad Hossein Mohammadi   +5 more
wiley   +1 more source

Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma. [PDF]

Transl Oncol
Liu J, Chen J, Chen S, Huang Y, Xu K, Cai D, Liao X, You R, Xu X, Wang X, Hou D, Zhang S, Yang F, Huang H.   +13 more
europepmc   +1 more source

A comprehensive review on adaptive plasticity and recovery mechanisms post‐acquired brain injury

Neuroprotection, EarlyView.
This figure illustrates the dynamic process of neurogenesis following brain injury, focusing on the roles of neural stem and progenitor cells at the injury site. Key mechanisms include axonal sprouting, synaptogenesis, dendritic remodeling, and brain‐derived neurotrophic factor signaling via TrkB receptors.
Ravi Kumar Rajan
wiley   +1 more source

Peripheral T-Cell Lymphoma: What's Next? [PDF]

Hematol Oncol
Yoon SE, Kim WS.
europepmc   +1 more source

Lymphoid Malignancies in Ataxia–Telangiectasia: Experience with Novel Targeted Therapies

Pediatric Blood &Cancer, Volume 72, Issue 9, September 2025.
ABSTRACT Patients with ataxia–telangiectasia (AT) face unique challenges in managing lymphoid malignancies due to heightened sensitivity to chemotherapy and radiation, requiring alternative treatment strategies. This report presents three cases demonstrating the successful integration of targeted therapies: ibrutinib for diffuse large B‐cell lymphoma ...
Samanta Catueno, Ramya Ramakrishnan, Sarah Elitzur, Miriam B. Garcia, David McCall, Cesar Nunez, Michael Roth, Alessandra Ferrajoli, Branko Cuglievan, Amber Gibson   +9 more
wiley   +1 more source

Antitumor effects of human antithymocyte globulin on peripheral T cell lymphoma via complement-dependent and -independent cytotoxicity in xenograft mouse models. [PDF]

Clin Exp Med
Gao BB, Zhang TQ, Zhang JJ, Wang HN, Huang D, Zhang XH, Kang ZJ, Yang Y, Liu XL, Sun C, Shao J, Yan JS.   +11 more
europepmc   +1 more source

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

British Journal of Haematology, 2015
F. Foss, R. Advani, M. Duvic, K. Hymes, T. Intragumtornchai, A. Lekhakula, O. Shpilberg, A. Lerner, R. Belt, E. Jacobsen, G. Laurent, D. Ben-yehuda, M. Beylot‐Barry, U. Hillen, P. Knoblauch, G. Bhat, S. Chawla, L. F. Allen, B. Pohlman   +18 more
semanticscholar   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary central nervous system lymphoma: a case report. [PDF]

BMC Neurol
Zhang Z, Ling C, Zhang Y, Sun W, Wang Z, Meng L.   +5 more
europepmc   +1 more source